Adverse disease factors and risk stratification
. | No. . | % . | Marrow, n = 35 (%) . | Blood, n = 42 (%) . | P . |
---|---|---|---|---|---|
Adverse factor | |||||
Age, older than 30 y | 36 | 47 | 14 (40) | 22 (52) | .28 |
t(4;11) or t(9;22) | 9 | 12 | 5 (14) | 4 (10) | .52 |
Time to CR, more than 4 wk | 9 | 12 | 5 (14) | 4 (10) | .52 |
Risk stratification | |||||
Standard, 0 adverse factors | 36 | 47 | 19 (54) | 17 (40) | .39 |
Intermediate, 1 adverse factor | 28 | 36 | 10 (29) | 18 (43) | |
High, 2 adverse factors | 13 | 17 | 6 (17) | 7 (17) |
. | No. . | % . | Marrow, n = 35 (%) . | Blood, n = 42 (%) . | P . |
---|---|---|---|---|---|
Adverse factor | |||||
Age, older than 30 y | 36 | 47 | 14 (40) | 22 (52) | .28 |
t(4;11) or t(9;22) | 9 | 12 | 5 (14) | 4 (10) | .52 |
Time to CR, more than 4 wk | 9 | 12 | 5 (14) | 4 (10) | .52 |
Risk stratification | |||||
Standard, 0 adverse factors | 36 | 47 | 19 (54) | 17 (40) | .39 |
Intermediate, 1 adverse factor | 28 | 36 | 10 (29) | 18 (43) | |
High, 2 adverse factors | 13 | 17 | 6 (17) | 7 (17) |